First-of-its-kind multi-year collaboration
established to co-develop innovative artificial intelligence-based
decision support tools for robotic-assisted joint
surgery
WARSAW,
Ind. and NEW YORK,
July 28,
2022 /PRNewswire/ -- Zimmer Biomet Holdings, Inc.
(NYSE and SIX: ZBH), a global medical technology leader, and
Hospital for Special Surgery (HSS), the world's leading academic
medical center focused on musculoskeletal health, today announced a
first-of-its-kind, three-year agreement to create the HSS/Zimmer
Biomet (ZB) Innovation Center for Artificial Intelligence (AI) in
Robotic Joint Replacement. Through the collaboration, ZB and HSS
aim to develop new decision support tools, powered by data
collection and machine learning, to provide data-driven
recommendations to surgeons for robotic-assisted joint surgery.
"Forging a multi-year collaboration with a leading orthopedics
institution combines HSS' clinical expertise with Zimmer Biomet's
expertise in surgical robotics and AI modeling," said Ivan Tornos,
Chief Operating Officer at Zimmer Biomet. "This agreement, which is
our second collaboration with HSS in two years, advances our vision
to accelerate impactful innovation through strategic third-party
relationships."
The decision support tools, which will be integrated into the
ROSA® Knee and ROSA® Hip systems, will
further expand the capabilities of ZB's ZBEdge™ suite of
smart, digital and robotic technologies designed to deliver
transformative data-powered clinical insights with the goal of
improving patient outcomes.
"As a world leader in orthopedics, we strive to find
opportunities to innovate towards improving patient care," said
Michael P. Ast, MD, Chief Medical
Innovation Officer at HSS. "Leveraging data analytics and AI in
this collaboration could enable us to improve clinical results in
robotic-assisted joint replacement surgeries."
Over the course of the collaboration, a team of HSS surgeons and
ZB data scientists will work together to develop and test
hypotheses that use data-driven insights to address common clinical
challenges associated with joint replacement surgery. The goal is
to use the validated hypotheses to inform the development of
algorithms for the decision support tools.
"Through this unique collaboration, HSS can apply our knowledge
and expertise to transform musculoskeletal care with innovative
technologies that can improve clinical outcomes, patient experience
and cost efficiency in a meaningful way," said Louis A. Shapiro, President and CEO at HSS.
"Together we hope to create clinically validated decision
support tools that rely on real-world patient and procedural data
to inform actionable recommendations that help surgeons achieve
predictable and reproducible clinical outcomes," said Nitin Goyal, MD, Chief Science, Technology and
Innovation Officer at Zimmer Biomet.
About Zimmer Biomet
Zimmer Biomet is a global medical technology leader
with a comprehensive portfolio designed to maximize mobility and
improve health. We seamlessly transform the patient experience
through our innovative products and suite of integrated digital and
robotic technologies that leverage data, data analytics and
artificial intelligence.
With 90+ years of trusted leadership and proven expertise,
Zimmer Biomet is positioned to deliver the highest quality
solutions to patients and providers. Our legacy continues to come
to life today through our progressive culture of evolution and
innovation.
For more information about our product portfolio, our operations
in 25+ countries and sales in 100+ countries or about joining our
team, visit www.zimmerbiomet.com or follow Zimmer Biomet
on Twitter at www.twitter.com/zimmerbiomet.
About HSS
HSS is the world's leading academic medical center focused on
musculoskeletal health. At its core is Hospital for Special
Surgery, nationally ranked No. 1 in orthopedics (for the 13th
consecutive year), No. 4 in rheumatology by U.S. News & World
Report (2021-2022), and the best pediatric orthopedic hospital in
NY, NJ and CT by U.S. News & World Report "Best Children's
Hospitals" list (2021-2022). In a survey of medical professionals
in more than 20 countries by Newsweek, HSS is ranked world #1 in
orthopedics for a second consecutive year (2022). Founded in 1863,
the Hospital has the lowest complication and readmission rates in
the nation for orthopedics, and among the lowest infection rates.
HSS was the first in New York
State to receive Magnet Recognition for Excellence in
Nursing Service from the American Nurses Credentialing Center five
consecutive times. An affiliate of Weill Cornell Medical College,
HSS has a main campus in New York
City and facilities in New
Jersey, Connecticut and in
the Long Island and Westchester County regions of New York State, as well as in Florida. In addition to patient care, HSS
leads the field in research, innovation and education. The HSS
Research Institute comprises 20 laboratories and 300 staff members
focused on leading the advancement of musculoskeletal health
through prevention of degeneration, tissue repair and tissue
regeneration. The HSS Innovation Institute works to realize the
potential of new drugs, therapeutics and devices. The HSS Education
Institute is a trusted leader in advancing musculoskeletal
knowledge and research for physicians, nurses, allied health
professionals, academic trainees, and consumers in more than 145
countries. The institution is collaborating with medical centers
and other organizations to advance the quality and value of
musculoskeletal care and to make world-class HSS care more widely
accessible nationally and internationally. www.hss.edu.
ZBH-Corp
Contacts:
|
|
Zimmer
Biomet
|
Hospital for Special
Surgery
|
Meredith Weissman
(Media)
|
Tracy
Hickenbottom
|
(703) 346-3127
|
(212)
606-1197
|
meredith.weissman@zimmerbiomet.com
|
MediaRelations@HSS.edu
|
|
|
Keri Mattox
(Investors)
|
|
(215) 275-2431
|
|
keri.mattox@zimmerbiomet.com
|
|
|
|
Ezgi Yagci (Investors)
|
|
(617) 549-2443
|
|
ezgi.yagci@zimmerbiomet.com
|
|
View original content to download
multimedia:https://www.prnewswire.com/news-releases/zimmer-biomet-and-hospital-for-special-surgery-hss-announce-creation-of-the-hsszimmer-biomet-innovation-center-for-artificial-intelligence-in-robotic-joint-replacement-301594874.html
SOURCE Zimmer Biomet Holdings, Inc.